Laurel Wealth Advisors (California)’s Vertex Pharmaceuticals VRTX Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio VRTX Stock Details VRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$497K	Sell
2022 Q3	$504K	Sell
2022 Q2	$621K	Sell
2022 Q1	$698K	Sell
2021 Q4	$639K	Buy
2016 Q2	–	Hold
2016 Q1	–	Hold